Q2 2023 · 13F-HR
M28 Capital Management LPholdings as filed
Filed 2023-08-11 · accession 0000902664-23-004379
$75.7M
Reported value
12
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $25.7M | 33.9% | 7,050,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $12.5M | 16.6% | 630,380 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $9.7M | 12.8% | 9,248,250 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $5.2M | 6.85% | 197,700 | Common | SOLE |
| 231269200 | — | CURIS INC | $5.0M | 6.58% | 6,000,000 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $3.7M | 4.86% | 346,190 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.5M | 4.68% | 142,500 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $3.1M | 4.09% | 1,910,600 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $2.9M | 3.78% | 166,200 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $2.4M | 3.18% | 67,400 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $2.0M | 2.64% | 363,800 | Common | SOLE |
| 65344D109 | — | NEXIMMUNE INC | $37,604 | 0.05% | 133,442 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.